The ideal pharmacological treatment for smoking cessation in hospitalized patients with co-morbid conditions, who are often on polypharmacotherapy, should be handy, effective, safe, and well-tolerated in order to prevent further compromising their health
Archived from the original on April 14, 2019
These findings align with previous studies ( Half of the participants reported daily e-cigarette use, and a notable preference for high nicotine concentrations (16 mg) was observed
We demonstrated that miR-125a-5p targets the 3'-UTR of Sp1 mRNA, and that its overexpression is related to the inhibition of luciferase activity
A change in UK epistaxis management
Educational and publicity campaigns should aim to debunk smokers misperception that smoking is a symbol of personal freedom and rectify their undue reliance on willpower